Wall Street Journal (blog) - Jacob Goldstein - Jan 19, 2010
Last summer, the government in Manila put price controls on several drugs, including Pfizer's Norvasc and Lipitor. Pfizer had previously offered to cut the ...
Wall Street Journal - James Hookway - Jan 18, 2010
Those drugs included Pfizer Inc.'s Norvasc and Lipitor medications, as well as GlaxoSmithKline's Augmentin antibiotic drug. Government officials said some ...
Sales declined for anti-hypertension drug Norvasc and smoking-cessation treatment Chantix. Pfizer recorded sales of Wyeth products beginning with the ...
The maker of Viagra and cholesterol fighter Lipitor, which paid $68 billion to get Wyeth's vaccines, biologic drugs and consumer health staples such as ...
... version of Pfizer's Caduet® (atorvastatin calcium - the active ingredient in Lipitor®, and amlodipine besylate - the active ingredient in Norvasc®, ...
Lipitor sales edged up just 1 percent to $3.18 billion in the quarter and blockbuster blood pressure drug Norvasc, which is steadily losing sales to generic ...
Generic competition hurt the blood pressure treatment Norvasc (amlodipine), which fell 10% to $486 million, while sales of the smoking cessation drug ...
... long-term chronic conditions including Lipitor, its cholesterol-reducing medicine. It said its experience with Norvasc, its blood pressure control drug, ...
These representatives would market Pfizer vaccines, anti-cancer drugs, anti-cholesterol medicine Lipitor, anti-hypertension drug Norvasc and antibiotic ...
Pfizer's Lipitor cholesterol pill and Norvasc blood pressure treatment, as well as the Plavix blood thinner from Bristol-Myers Squibb Co. and Sanofi-Aventis ...
Email this story